POM Investment Strategies’s Boston Scientific BSX Stock Holding History

POM Investment Strategies’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.48K	Buy	58 +19	+49%	+$1.03K	﹤0.01%	260
2026 Q1	$2.45K	Sell	39 -204	-84%	-$16.3K	﹤0.01%	335
2025 Q4	$23.2K	Buy	243 +227	+1,419%	+$22.3K	0.01%	106
2025 Q3	$1.56K	Buy	+16	New	+$1.66K	﹤0.01%	170
2024 Q3	–	Sell	-58	Closed	-$4.47K	–	322
2024 Q2	$4.47K	Buy	+58	New	+$4.25K	﹤0.01%	231

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

POM Investment Strategies's BSX Position: Q2 2026 in Review

POM Investment Strategies increased its Boston Scientific (BSX) stake by 49% in Q2 2026, buying an estimated $1.03K and bringing the position to 58 shares worth $2.48K. The position accounts for ﹤0.01% of the portfolio, ranked #260.

POM Investment Strategies first reported a position in BSX in Q2 2024 and has held it in 5 quarters since. The position peaked at $23.2K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

POM Investment Strategies held 58 shares of Boston Scientific worth $2.48K as of Q2 2026.
POM Investment Strategies bought 19 Boston Scientific shares in Q2 2026, an estimated $1.03K.
Boston Scientific made up ﹤0.01% of POM Investment Strategies's portfolio in Q2 2026, its #260 holding.
POM Investment Strategies first reported a position in Boston Scientific in Q2 2024 and has held it in 5 quarters since.
POM Investment Strategies's Boston Scientific position peaked at $23.2K in Q4 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on POM Investment Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.